Johnson & Johnson COVID-19 vaccine paused on Navajo reservation

The CDC and FDA recommended a pause in the use of the vaccine based on six reported U.S. cases of a rare and severe type of blood clot in individuals after receiving the Johnson & Johnson vaccine.The CDC and FDA recommended a pause in the use of the vaccine based on six reported U.S. cases of a rare and severe type of blood clot in individuals after receiving the Johnson & Johnson vaccine.